Pamela Gustafson
Nessuna posizione attualmente
Profilo
Pamela Gustafson worked as a Director of Clinical Operations at Trine Pharmaceuticals, a Project Manager at PAREXEL International Corp., LeukoSite, Inc., and Aai International, Inc. She also served as Vice President of Clinical Research at Proteon Therapeutics, Inc. Gustafson holds a graduate degree from Boston University and an undergraduate degree from Wheaton College (Illinois).
Precedenti posizioni note di Pamela Gustafson
| Società | Posizione | Fine |
|---|---|---|
Trine Pharmaceuticals, Inc.
 Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA. | Direttore Tecnico/Scientifico/R&S | 01/01/2006 |
| Aai International, Inc. | Corporate Officer/Principal | 01/01/2002 |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Corporate Officer/Principal | 01/01/1999 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | 01/01/1998 |
| PROTARA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Pamela Gustafson
| Wheaton College (Illinois) | Undergraduate Degree |
| Boston University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
Trine Pharmaceuticals, Inc.
Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA. | Health Technology |
| Aai International, Inc. | |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Health Technology |
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
- Borsa valori
- Insiders
- Pamela Gustafson
